Overview:
Explore how EpiIntestinal™—a human-relevant 3D small intestine tissue model—enhances drug discovery and preclinical development. This white paper details its ability to predict drug absorption, metabolism, and gastrointestinal toxicity more accurately than traditional models, reducing reliance on animal testing and improving translational success. Learn why EpiIntestinal™ is a powerful tool for compound efficacy and safety screening.
Resource type: White Paper
Page Count: 4 pages
Read Time: 7 minutes
Key Takeaways:
- Human-Relevant Model: EpiIntestinal™ mimics the human small intestine for accurate drug testing.
- Improved Predictivity: Outperforms traditional Caco-2 and animal models in absorption and toxicity studies.
- Comprehensive Testing: Enables drug metabolism, absorption, and gastrointestinal toxicity assessment.
- Cost & Time Efficiency: Reduces reliance on expensive, lengthy animal studies.
- Versatile Applications: Supports preclinical drug development and compound efficacy screening.
